These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


498 related items for PubMed ID: 19538959

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Is the expression of genes encoding enzymes of glutathione (GSH) metabolism involved in chloroquine resistance in Plasmodium chabaudi parasites?
    Ferreira ID, Nogueira F, Borges ST, do Rosário VE, Cravo P.
    Mol Biochem Parasitol; 2004 Jul; 136(1):43-50. PubMed ID: 15138066
    [Abstract] [Full Text] [Related]

  • 3. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway.
    Safeukui I, Mangou F, Malvy D, Vincendeau P, Mossalayi D, Haumont G, Vatan R, Olliaro P, Millet P.
    Biochem Pharmacol; 2004 Nov 15; 68(10):1903-10. PubMed ID: 15476661
    [Abstract] [Full Text] [Related]

  • 4. Antimalarial dual drugs based on potent inhibitors of glutathione reductase from Plasmodium falciparum.
    Friebolin W, Jannack B, Wenzel N, Furrer J, Oeser T, Sanchez CP, Lanzer M, Yardley V, Becker K, Davioud-Charvet E.
    J Med Chem; 2008 Mar 13; 51(5):1260-77. PubMed ID: 18260613
    [Abstract] [Full Text] [Related]

  • 5. Synergistic interaction of a chloroquine metabolite with chloroquine against drug-resistant malaria parasites.
    Kalkanidis M, Klonis N, Tschan S, Deady LW, Tilley L.
    Biochem Pharmacol; 2004 Apr 01; 67(7):1347-53. PubMed ID: 15013850
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synergy of human immunodeficiency virus protease inhibitors with chloroquine against Plasmodium falciparum in vitro and Plasmodium chabaudi in vivo.
    He Z, Qin L, Chen L, Peng N, You J, Chen X.
    Antimicrob Agents Chemother; 2008 Jul 01; 52(7):2653-6. PubMed ID: 18443126
    [Abstract] [Full Text] [Related]

  • 8. Synergy of the antiretroviral protease inhibitor indinavir and chloroquine against malaria parasites in vitro and in vivo.
    Li X, He Z, Chen L, Li Y, Li Q, Zhao S, Tao Z, Hu W, Qin L, Chen X.
    Parasitol Res; 2011 Dec 01; 109(6):1519-24. PubMed ID: 21537980
    [Abstract] [Full Text] [Related]

  • 9. Saquinavir inhibits the malaria parasite's chloroquine resistance transporter.
    Martin RE, Butterworth AS, Gardiner DL, Kirk K, McCarthy JS, Skinner-Adams TS.
    Antimicrob Agents Chemother; 2012 May 01; 56(5):2283-9. PubMed ID: 22354298
    [Abstract] [Full Text] [Related]

  • 10. A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline.
    Davioud-Charvet E, Delarue S, Biot C, Schwöbel B, Boehme CC, Müssigbrodt A, Maes L, Sergheraert C, Grellier P, Schirmer RH, Becker K.
    J Med Chem; 2001 Nov 22; 44(24):4268-76. PubMed ID: 11708927
    [Abstract] [Full Text] [Related]

  • 11. Roxithromycin potentiates the effects of chloroquine and mefloquine on multidrug-resistant Plasmodium falciparum in vitro.
    Min TH, Khairul MF, Low JH, Che Nasriyyah CH, A'shikin AN, Norazmi MN, Ravichandran M, Raju SS.
    Exp Parasitol; 2007 Apr 22; 115(4):387-92. PubMed ID: 17118354
    [Abstract] [Full Text] [Related]

  • 12. Malagashanine potentiates chloroquine antimalarial activity in drug resistant Plasmodium malaria by modifying both its efflux and influx.
    Ramanitrahasimbola D, Rasoanaivo P, Ratsimamanga S, Vial H.
    Mol Biochem Parasitol; 2006 Mar 22; 146(1):58-67. PubMed ID: 16313982
    [Abstract] [Full Text] [Related]

  • 13. Investigation of 7-benzylidenenaltrexone derivatives as resistance reverser for chloroquine-resistant Plasmodium chabaudi.
    Miyata Y, Fujii H, Uenohara Y, Kobayashi S, Takeuchi T, Nagase H.
    Bioorg Med Chem Lett; 2012 Aug 15; 22(16):5174-6. PubMed ID: 22818080
    [Abstract] [Full Text] [Related]

  • 14. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum.
    Meierjohann S, Walter RD, Müller S.
    Biochem J; 2002 Dec 15; 368(Pt 3):761-8. PubMed ID: 12225291
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo chloroquine-potentiating action of Strychnos myrtoides alkaloids against chloroquine-resistant strains of Plasmodium malaria.
    Rasoanaivo P, Ratsimamanga-Urverg S, Milijaona R, Rafatro H, Rakoto-Ratsimamanga A, Galeffi C, Nicoletti M.
    Planta Med; 1994 Feb 15; 60(1):13-6. PubMed ID: 8134408
    [Abstract] [Full Text] [Related]

  • 16. Chloroquine-induced nitric oxide increase and cell death is dependent on cellular GSH depletion in A172 human glioblastoma cells.
    Park BC, Park SH, Paek SH, Park SY, Kwak MK, Choi HG, Yong CS, Yoo BK, Kim JA.
    Toxicol Lett; 2008 Apr 21; 178(1):52-60. PubMed ID: 18359172
    [Abstract] [Full Text] [Related]

  • 17. Antiretrovirals as antimalarial agents.
    Skinner-Adams TS, McCarthy JS, Gardiner DL, Hilton PM, Andrews KT.
    J Infect Dis; 2004 Dec 01; 190(11):1998-2000. PubMed ID: 15529265
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of a protein tyrosine kinase activity in Plasmodium falciparum by chloroquine.
    Sharma A, Mishra NC.
    Indian J Biochem Biophys; 1999 Oct 01; 36(5):299-304. PubMed ID: 10844978
    [Abstract] [Full Text] [Related]

  • 19. Double-drug development against antioxidant enzymes from Plasmodium falciparum.
    Biot C, Dessolin J, Grellier P, Davioud-Charvet E.
    Redox Rep; 2003 Oct 01; 8(5):280-3. PubMed ID: 14962365
    [Abstract] [Full Text] [Related]

  • 20. Antimalarial activity of methanolic extracts from plants used in Kenyan ethnomedicine and their interactions with chloroquine (CQ) against a CQ-tolerant rodent parasite, in mice.
    Muregi FW, Ishih A, Miyase T, Suzuki T, Kino H, Amano T, Mkoji GM, Terada M.
    J Ethnopharmacol; 2007 Apr 20; 111(1):190-5. PubMed ID: 17145149
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.